Language selection

Search

Details for: TEVA-OLANZAPINE

Company: TEVA CANADA LIMITED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02276712TEVA-OLANZAPINEOLANZAPINE2.5 MGTABLETORAL
02276720TEVA-OLANZAPINEOLANZAPINE5 MGTABLETORAL
02276739TEVA-OLANZAPINEOLANZAPINE7.5 MGTABLETORAL
02276747TEVA-OLANZAPINEOLANZAPINE10 MGTABLETORAL
02276755TEVA-OLANZAPINEOLANZAPINE15 MGTABLETORAL
02359707TEVA-OLANZAPINEOLANZAPINE20 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: